Cargando…
Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation
BACKGROUND: New therapeutic targets for cardiac hypertrophy, an independent risk factor for heart failure and death, are essential. HNO is a novel redox sibling of NO• attracting considerable attention for the treatment of cardiovascular disorders, eliciting cGMP-dependent vasodilatation yet cGMP-in...
Autores principales: | Lin, Eliane Q., Irvine, Jennifer C., Cao, Anh H., Alexander, Amy E., Love, Jane E., Patel, Ruchi, McMullen, Julie R., Kaye, David M., Kemp-Harper, Barbara K., Ritchie, Rebecca H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323591/ https://www.ncbi.nlm.nih.gov/pubmed/22506056 http://dx.doi.org/10.1371/journal.pone.0034892 |
Ejemplares similares
-
The novel NO redox sibling, nitroxyl (HNO), prevents cardiomyocyte hypertrophy and superoxide generation via cGMP
por: Ritchie, Rebecca, et al.
Publicado: (2009) -
The nitroxyl donor isopropylamine-NONOate elicits soluble guanylyl cyclase-dependent antihypertrophic actions: comparison of the potential therapeutic advantages of HNO over NO•
por: Ritchie, Rebecca, et al.
Publicado: (2013) -
The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
por: Irvine, Jennifer C., et al.
Publicado: (2012) -
Soluble guanylyl cyclase mediates concomitant coronary vasodilator and positive inotropic actions of the HNO donor Angeli's salt in the intact rat heart
por: Ritchie, Rebecca, et al.
Publicado: (2013) -
The Effects of Nitroxyl (HNO) on Soluble Guanylate Cyclase Activity: INTERACTIONS AT FERROUS HEME AND CYSTEINE THIOLS
por: Miller, Thomas W., et al.
Publicado: (2009)